The Price Is Right For RxSight, Inc. (NASDAQ:RXST) - simplywall.st
2 hours ago • Google News
Rxsight Inc (RXST)
US$ 14.951.53%
Price Chart
Key Statistics
Market Cap
$ 572.58M
P/E Ratio
0.00
Revenue (TTM)
$ 148.31M
Volume
979.03K
52W High
$ 60.81
52W Low
$ 12.53
Dividend Yield
0.00%
Beta
1.29
Technicals
50-Day MA
14.9284
200-Day MA
33.7151
52 Week High
60.81
52 Week Low
12.53
About RXST
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in th.
Employees
498
Headquarters
Aliso Viejo, CA
CEO
Dr. Ronald M. Kurtz M.D.
Latest News
When (RXST) Moves Investors should Listen - news.stocktradersdaily.com
Yesterday • Google News
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued - MSN
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg